S.2710

The Open Payments Expansion Act requires pharmaceutical and device manufacturers to disclose payments made to patient advocacy organizations.

The Open Payments Expansion Act amends title XI of the Social Security Act to mandate that pharmaceutical and device manufacturers publicly disclose covered payments made to patient advocacy organizations. These organizations must be exempt from taxation under the Internal Revenue Code and provide education, advocacy, and support services for patients and caregivers. The bill defines "covered payment" as any payment or other transfer of value, including indirect payments made through a third party.